Status:
COMPLETED
The Effect of Treatment With Umbilical Cord Blood Platelet Lysate on Diabetic Foot Ulcers
Lead Sponsor:
Attikon Hospital
Collaborating Sponsors:
Biomedical Research Foundation, Academy of Athens
Conditions:
Diabetic Foot
Eligibility:
All Genders
18-95 years
Phase:
PHASE4
Brief Summary
Application of autologous Platelet Rich Plasma (PRP) has been a major breakthrough for the treatment of diabetic foot ulcers, as it provides the necessary growth factors which enhance tissue healing. ...
Detailed Description
110 patients with diabetic foot ulcer will be randomized to receive UCB-PL gel or regular dressing with normal saline. The diabetic foot ulcers will be first debrided to remove any necrotic and infect...
Eligibility Criteria
Inclusion
- age\>18 years old
- patients with diabetic foot ulcer, foot ulcer located on the plantar, medial, or lateral aspect of the foot (including all toe surfaces)
- ulcer with area(length x width) measurement\<30 cm2
- non-infected ulcers
Exclusion
- pregnacy
- venous ulcers
- clinical signs and symptoms of infection
- exposure of bone, muscle, ligaments, or tendons and the presence of tunneling
Key Trial Info
Start Date :
June 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05404295
Start Date
June 10 2019
End Date
March 30 2023
Last Update
December 5 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Catherine Stavropoulos-Giokas
Athens, Attica, Greece, 11527
2
Vaia Lambadiari
Athens, Attica, Greece, 12462